Wednesday, Jan 24 2018 | Time 03:38 Hrs(IST)
image
  • Double car bombing in Libya's Benghazi kills at least 11 - officials, witness
  • 'Wonder Woman' stumbles, 'Get Out' surprises at Oscar nominations
  • Protest against 'Padmaavat' turns violent in Gujarat
  • Thousands march against Trump in Swiss financial capital
Startup World Share

Digital health technology startup Doxper raises seed round from Vidal, growX

Digital health technology startup Doxper  raises seed round from Vidal, growX

Mumbai, Aug 28(UNI) Heathtech startup InformDS Technologies Pvt. Ltd. which runs Doxper, has raised USD750,000 in its seed round of investment led by Vidal Healthcare and GrowX Ventures. Others who participated in the round include angel investment platform Capier Investments, online venture capital firm Globevestor, and other angel investors including a leading onco-surgeon, company press release said. As part of the deal, Girish Rao, managing director of Vidal Healthcare, and Siddharth Dhondiyal, representing GrowX Ventures have joined Doxper’s board of directors. The startup will use the fresh capital to scale up operations and develop its technology platform by adding more layers such as machine learning, handwriting recognition and artificial intelligence on top of the current stack, Shailesh Prithani, co-founder and chief executive of the firm said in the statement. Doxper has developed an encoded pen and paper system, through which doctors can write prescriptions and patient information, and the data automatically gets transferred to the cloud. Patients can use the Doxper app to access their records, book follow-on appointments, and share reports with their family. Hospitals can also use Doxper to digitise their records by integrating their HIS system. 'The problem of not recording healthcare data in digital format is an expensive one and when solved has benefits of exponential proportions. The simplicity of the solution is the biggest USP of Doxper,' Rao and Dhondiyal said in the statement. Doxper is actively servicing doctors in Delhi/NCR, Jaipur, Pune, Bangalore and Mumbai. It also remotely supports a few doctors in other cities who are early adopters with keen interest in technology and its solution. The company claims that over 400 leading physicians and specialists have become its users, including AIIMS Breast Cancer Clinic, Prashanti Cancer Care Mission, Biocon Foundation, Jain Fertility & Mother Care Hospital, and others. The firm is also piloting with large hospitals. Several platforms offering doctor consultation services have recently secured funding. UNI JS NV1328

More News
Camfil launches City M Indoor Air Purifier in India

Camfil launches City M Indoor Air Purifier in India

20 Nov 2017 | 5:05 PM

Mumbai, Nov 20 (UNI) Camfil, a global leader in industrial air purification, today announced the launch of it's advanced indoor air purifier, City M.

 Sharesee more..
MG Motor India begins quest for next big tech startup

MG Motor India begins quest for next big tech startup

16 Nov 2017 | 6:18 PM

New Delhi, Nov 16 (UNI) MG Motor India has embarked upon a quest to collaborate with technology startups in the country as the British automotive marque “MG”, which recently inaugurated its first manufacturing facility at Halol in Gujarat, aims to bring additional synergies to its automotive business in the coming years, especially in the areas of telematics and manufacturing.

 Sharesee more..
DishTV launches 'Advanced DishTV interface'

DishTV launches 'Advanced DishTV interface'

13 Sep 2017 | 4:44 PM

Mumbai, Sept 13 (UNI) DishTV, Asia’s largest DTH operator, announced the launch of ‘Advanced DishTV interface’ (ADI), world’s first AI-enabled pay-tv Chatbot.

 Sharesee more..
Women rehabilitated under ‘Muktir Alo’ scheme open cafeteria

Women rehabilitated under ‘Muktir Alo’ scheme open cafeteria

04 Sep 2017 | 1:14 PM

Kolkata, Sep 4 (UNI) Muktir Alo is a scheme run by the West Bengal Government for the rehabilitation of women who have been trafficked for prostitution.

 Sharesee more..
Ajanta Pharma launches Eletriptan Hydrobromide Tablets in US market

Ajanta Pharma launches Eletriptan Hydrobromide Tablets in US market

31 Aug 2017 | 3:30 PM

Mumbai, Aug 31(UNI) Pharma Major, Ajanta Pharma has launched Eletriptan Hydrobromide Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA.

 Sharesee more..
image